Skip to main content

User account menu

  • My EPI-CE Documentation
  • Log in
ExosomeDx logo

User account menu

  • My EPI-CE Documentation
  • Log in

Webinars

  • Learn About Research and Clinical Applications of Exosome Based Liquid Biopsies

    Webinar Nov 13, 2019

    Listen as Dr. Skog breaks down the science behind exosome-based liquid-biopsies and how they can be used to address diagnostic uncertainty in the field of prostate cancer.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3

+49 89 416 17270
exosomedx.info@bio-techne.com
Exosome Diagnostics GmbH
Am Klopferspitz 19a
82152 Martinsried
Germany

Social navigation

  • Facebook
  • Twitter
  • LinkedIn

Iso LogoThe EPI-CE test was developed by Exosome Diagnostics, Inc. according to the European Union directive for in-vitro diagnostic devices IVDD (98/79/EC) and the performance characteristics determined by Exosome Diagnostics, Inc. The test performance has been verified in Exosome Diagnostics GmbH's clinical laboratories in Martinsried, Germany. Exosome Diagnostics GmbH is accredited by Dakks to ISO 15189. Exosome Diagnostics and ExoDx are registered trademarks of Exosome Diagnostics, Inc.

© 2026 ExoDx